GlassScriptPhysician profile
Jillian Manng
NPI 1346779626
$2,100.45
in general payments reported to CMS, 2019-2025
12 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $406 · 2023: $636 · 2024: $719 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.94 | 2022-2023 | |
| Madrigal Pharmaceuticals | $400.82 | 2024-2025 | Rezdiffra, Resmetirom |
| Boston Scientific Corporation | $327.56 | 2022-2025 | General - Hemostasis |
| Regeneron Pharmaceuticals, INC. | $146.24 | 2024 | Dupixent |
| Genzyme Corporation | $144.03 | 2024 | |
| Phathom Pharmaceuticals, INC. | $123.11 | 2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $120.21 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $119.32 | 2023 | |
| Axonics, INC. | $112.76 | 2023 | Bulkamid, Axonics |
| Enterra Medical, INC. | $99.92 | 2022 | |
| Celgene Corporation | $33.54 | 2023 | Zeposia |
| Intercept Pharmaceuticals, INC. | $30.00 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Manng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.